EichorEICHOR
Condition: Polymyositis Dermatomyositis Synced from ClinicalTrials.gov · August 03, 2026

Recruiting studies: Polymyositis Dermatomyositis

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

BCMA-CD19 cCAR-T for the Treatment of Refractory Inflammatory Myopathy
Phase 1 · 1 location(s) · iCell Gene Therapeutics · NCT07715136Severity Factors of Dermatomyositis in the Caribbean Population - DM-ANTILLES
Phase N/A · 1 location(s) · Centre Hospitalier Universitaire de la Guadeloupe · NCT07265999Clinical Study of BCMA/CD70-targeted CAR-T Therapy for Refractory Pediatric Rheumatic Diseases
Phase 1 · 1 location(s) · Chongqing Precision Biotech Co., Ltd · NCT07184450Intralesional Injection of STS in Treatment of Calcinosis
Phase 2 · 1 location(s) · Robyn T. Domsic, MD, MPH · NCT06672822A Study to Investigate Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of AZD5492 in Adult Participants Wit
Phase 1 · 37 location(s) · AstraZeneca · NCT06916806Safety and Efficacy of CD19 Targeted CAR-T Therapy for Refractory Autoimmune Disease
Phase 1 · 1 location(s) · Chongqing Precision Biotech Co., Ltd · NCT06056921Safety and Efficacy of ULSC on Disease Severity and Steroid Tapering in Participants With Dermatomyositis/ Polymyositis
Phase 2/Phase 3 · 2 location(s) · Restem, LLC. · NCT07160205Identification of Cutaneous and Blood Biomarkers Predictive of Response to Systemic Treatments During Chronic Inflammato
Phase N/A · 1 location(s) · Assistance Publique - Hôpitaux de Paris · NCT06599411Baricitinib in Patients With Relapsing or naïve Dermatomyositis
Phase 3 · 1 location(s) · Assistance Publique - Hôpitaux de Paris · NCT04972760A Study to Investigate the Efficacy and Safety of Anifrolumab Administered as Subcutaneous Injection and Added to Standa
Phase 3 · 236 location(s) · AstraZeneca · NCT06455449Photoacoustic/Ultrasound Imaging in Patients of Dermatomyositis With Calcinosis Cutis: Characteristic Findings and Treat
NA · 1 location(s) · Peking Union Medical College Hospital · NCT07037472Descartes-08 for Children, Adolescents, and Young Adults With Autoimmune Disorders
Phase 1/Phase 2 · 3 location(s) · Cartesian Therapeutics · NCT07089121Phase 1b Trial of RAY121 in Immunological Diseases (RAINBOW Trial)
Phase 1 · 77 location(s) · Chugai Pharmaceutical · NCT06371417Rheumatology Diet Study
Phase N/A · 1 location(s) · University of Central Florida · NCT06339957A Study to Investigate the Safety and Preliminary Efficacy of ALLO-329, an Allogeneic CAR T-cell Therapy, in Adults With
Phase 1 · 15 location(s) · Allogene Therapeutics · NCT07085104Descartes-08 in Autoantibody Myositis
Phase 2 · 2 location(s) · Cartesian Therapeutics · NCT07391605Clinico-biological Collection of Autoimmune, Dysimmune or Auto-inflammatory Dermatological Diseases
Phase N/A · 1 location(s) · University Hospital, Toulouse · NCT06387654Clinical Study of CD19 Targeted Universal Chimeric Antigen Receptor T Lymphocytes (UCAR-T) for the Treatment of Refracto
Phase 1 · 1 location(s) · Chongqing Precision Biotech Co., Ltd · NCT06686524Study of KYV-101 Anti-CD19 CAR T Therapy in Adult Dermatomyositis
Phase 1 · 2 location(s) · Stanford University · NCT06298019Anti-CD19 CAR T-Cell Therapy in Refractory Systemic Autoimmune Diseases
Phase 1/Phase 2 · 1 location(s) · Fondazione Policlinico Universitario Agostino Gemelli IRCCS · NCT06685042Panniculitis in Dermatomyositis
Phase N/A · 1 location(s) · University Hospital, Strasbourg, France · NCT07345949A Study to Understand How the Study Medicine Dazukibart Works in People With Idiopathic Inflammatory Myopathies
Phase 3 · 24 location(s) · Pfizer · NCT06698796Optimizing Treatment on Idiopathic Inflammatory Myopathies
Phase N/A · 1 location(s) · University of Sao Paulo · NCT03092180Clinical Trial of CD19-targeted CAR-T Therapy for Refractory Juvenile Dermatomyositis
Phase 1 · 1 location(s) · Chongqing Precision Biotech Co., Ltd · NCT06569472Adult and Juvenile Myositis
Phase N/A · 4 location(s) · National Institute of Environmental Health Sciences (NIEHS) · NCT00017914CAR-T Cells in Systemic B Cell Mediated Autoimmune Disease
Phase 1/Phase 2 · 1 location(s) · Miltenyi Biomedicine GmbH · NCT06347718A Long-Term Follow-Up Study for Participants Previously Treated With KYV-101
Phase N/A · 1 location(s) · Kyverna Therapeutics · NCT07403188Home Based Clinical Management of Interstitial Lung Disease in Systemic Rheumatic Diseases
NA · 1 location(s) · Oslo University Hospital · NCT06732674Exploratory Clinical Study of Anti-CD19/BCMA Universal CAR-T Cell Injection for the Treatment of Refractory Autoimmune D
NA · 1 location(s) · The First Affiliated Hospital with Nanjing Medical Universit · NCT07558850A Study to Understand How the Study Medicine (PF-06823859) Works in People With Active Idiopathic Inflammatory Myopathie
Phase 3 · 146 location(s) · Pfizer · NCT05895786
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →
Eichor
Clinical intelligence from public evidence
Use of Eichor is governed by our Terms of Use · Privacy Policy
© 2026 Biomedistats LLC (dba Eichor)

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.